https://www.selleckchem.com/products/ko143.html
High AFP levels at CR (20 ng/mL) were independently associated with a shorter PFS [hazard ratio (HR)=1.403] and OS (HR=1.284), together with tumor multiplicity at TACE (HR=1.518 and 1.666, respectively). AFP non-responders at CR (76.2%, n=359 of 471) showed a shorter PFS (median 10.5 months vs. 15.5 months, HR=1.375) and OS (median 41.4 months vs. 61.8 months, HR=1.424) than AFP responders (all =0.001). High AFP levels and AFP non-responders were independently associated with poor outcomes after TACE. AFP holds clinical implications f
Gefällt mir
Kommentar
Teilen
